scPharmaceuticals Inc. (SCPH)
scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product pipeline also includes scCeftriaxone, an antibiotic to treat infections caused by gram-positive and gram-negative organisms; and scCarbapenem program, an antibiotic for treating infections caused by gram-negative organisms. The company has a development agreement with West Pharmaceutical Services, Inc. for development of single use SmartDose device. scPharmaceuticals Inc. was incorporated in 2013 and is headquartered in Burlington, Massachusetts.
$263.15M
Mr. John H. Tucker
26.00
Burlington, MA
Nov 17, 2017
-3.37
$-1.56
10.75
17.12
-1,271.87%
-4.63
0.02
-0.86
54.55
15.75
-41.23%
27.48%
Similar stocks (7)
Iovance Biotherapeutics, Inc.
IOVA
DiaMedica Therapeutics Inc.
DMAC
Seres Therapeutics, Inc.
MCRB
Lyra Therapeutics, Inc.
LYRA
Monopar Therapeutics Inc.
MNPR
Pasithea Therapeutics Corp.
KTTA
Scopus BioPharma Inc.
SCPS
ETF Exposure (23)
Invesco NASDAQ Future Gen 200 ETF
QQQS
0.678%
iShares Micro-Cap ETF
IWC
0.03898%
iShares Russell 2000 Growth ETF
IWO
0.01108%
Vanguard Russell 2000 Growth Index Fund
VTWG
0.01%
Vanguard Russell 2000 Index Fund
VTWO
0.01%
iShares Russell 2000 ETF
IWM
0.00548%
ProShares Ultra Russell2000
UWM
0.0021830927056105853%
Dimensional U.S. Small Cap ETF
DFAS
0.00215221%
ProShares UltraPro Russell2000
URTY
0.0010751446721576179%
ProShares Hedge Replication ETF
HDG
9.130542304881916e-4%
iShares Russell 3000 ETF
IWV
0.0004%
Dimensional U.S. Core Equity 2 ETF
DFAC
5.846e-5%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Russell 3000 Index Fund
VTHR
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%
Similar stocks (7)
Iovance Biotherapeutics, Inc.
IOVA
DiaMedica Therapeutics Inc.
DMAC
Seres Therapeutics, Inc.
MCRB
Lyra Therapeutics, Inc.
LYRA
Monopar Therapeutics Inc.
MNPR
Pasithea Therapeutics Corp.
KTTA
Scopus BioPharma Inc.
SCPS
ETF Exposure (23)
Invesco NASDAQ Future Gen 200 ETF
QQQS
0.678%
iShares Micro-Cap ETF
IWC
0.03898%
iShares Russell 2000 Growth ETF
IWO
0.01108%
Vanguard Russell 2000 Growth Index Fund
VTWG
0.01%
Vanguard Russell 2000 Index Fund
VTWO
0.01%
iShares Russell 2000 ETF
IWM
0.00548%
ProShares Ultra Russell2000
UWM
0.0021830927056105853%
Dimensional U.S. Small Cap ETF
DFAS
0.00215221%
ProShares UltraPro Russell2000
URTY
0.0010751446721576179%
ProShares Hedge Replication ETF
HDG
9.130542304881916e-4%
iShares Russell 3000 ETF
IWV
0.0004%
Dimensional U.S. Core Equity 2 ETF
DFAC
5.846e-5%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Russell 3000 Index Fund
VTHR
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%